GlassScriptPhysician profile
Bette Carlson
NPI 1841238037
$755.23
in general payments reported to CMS, 2019-2025
15 companies · $248 in 2025
The $248 reported for 2025 was more than what 80% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $63.25 · 2021: $48.27 · 2022: $24.67 · 2023: $82.28 · 2024: $111 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $441.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $127.49 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $126.25 | 2023-2025 | Vaxneuvance, Gardasil 9, Rotateq |
| Sobi, INC | $123.00 | 2019 | |
| Glaxosmithkline, LLC. | $52.50 | 2019-2023 | Bexsero |
| Ars Pharmaceuticals Operations, INC. | $51.94 | 2025 | Neffy |
| Sanofi-Aventis U.S. LLC | $50.20 | 2024-2025 | |
| Cranial Technologies, INC | $49.91 | 2023-2025 | Doc Band |
| Astrazeneca Pharmaceuticals LP | $27.38 | 2024 | Flumist Quadrivalent |
| Genentech USA, INC. | $23.95 | 2020 | |
| Alk-Abello, INC | $23.90 | 2025 | Neffy |
| Abbott Laboratories | $23.39 | 2025 | Id Now Instrument |
| Collegium Pharmaceutical, INC. | $21.71 | 2025 | Jornay Pm |
| Mylan Pharmaceuticals INC. | $18.52 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.48 | 2020 | |
| Neos Therapeutics, LP | $16.61 | 2025 | Cotempla Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bette Carlson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.